Glaucoma and Reading Ability
What can be done to make reading easier for those with glaucoma? You can start by trying some things on your own.
Menu
Menu
This is the place for the latest information about our work here at Glaucoma Research Foundation and for current events in the world of eye health. All breakthroughs and insights are made possible through the dedication of researchers, and through the continued financial support and active involvement of the community.
This is the place for the latest information about our work here at Glaucoma Research Foundation and for current events in the world of eye health. All breakthroughs and insights are made possible through the dedication of researchers, and through the continued financial support and active involvement of the community.
What can be done to make reading easier for those with glaucoma? You can start by trying some things on your own.
New approaches to treating, managing, and even curing glaucoma are essential to patients and caregivers. Researchers are actively working to advance the field in several key areas.
Research outcomes from past Shaffer Grant recipients demonstrate the impact of this funding in catalyzing the growth, sustainability, and productivity of glaucoma research laboratories across the US.
August 29, 2018 — Alcon has issued a voluntary global recall of the CyPass microstent, effective immediately.
“I became interested in glaucoma because I liked the long-term aspect of it. It is through that long-term relationship that we can really get to know our patients and help them.” — Carla Siegfried, MD
A recent discovery from researchers at Massachusetts Eye and Ear and MIT is providing some new insights into what causes glaucoma.
Glaucoma Research Foundation Shaffer Grants present a unique opportunity for investigators to pursue innovative ideas in the spirit of high risk/high reward scientific discovery.
“Whatever curves life throws at us, I believe one must always make the best out of a situation; there is always a positive side.”
– Niki De Lara
Rhopressa 0.02% is a novel once-daily eye drop for lowering elevated intraocular pressure.
Generic drugs work well for most patients, but there are differences compared to the brand name products.
Concerns about driving often come up with glaucoma and may be brought to the doctor’s attention by the patient or a family member.
Glaucoma is a complex disease resulting from a mix of genetic and environmental factors. Family history is an important risk factor for glaucoma.
The Gleams Newsletter includes interviews, personal stories, and current information about glaucoma, new treatments, updates on research findings, and more. You can subscribe to the printed version of Gleams or the electronic version — both are free.
The Gleams Newsletter includes interviews, personal stories, and current information about glaucoma, new treatments, updates on research findings, and more. You can subscribe to the printed version of Gleams or the electronic version — both are free.
FOR EYECARE PROFESSIONALS
FOR EYECARE PROFESSIONALS
Glaucoma Research Foundation • 251 Post Street, Suite 600 • San Francisco, CA 94108 • 415-986-3162
Send us an email
We are a 501c3 tax-exempt national nonprofit. Our tax ID number is 94-2495035. Our EIN number is 94-2495035.
Copyright 2022 all rights reserved.
Print Subscription
(The printed edition of the Gleams newsletter is only available if you live in the United States or Canada)
You can unsubscribe at any time. GRF will not share your personal information with any other organizations. Please see our Privacy Policy for further information.
E-mail Subscription
You can unsubscribe at any time. GRF will not share your personal information with any other organizations. Please see our Privacy Policy for further information.